TOP stocks:

Apple

Shares of other companies:

Arch Capital Group Ltd

Ferguson Plc

Ameriprise Financial Inc

Cigna

Cintas Corporation

Tractor Supply Company

Velodyne Lidar

Zynex

Direct Digital Holdings

Alibaba

Forecast: (INCY) for today October 27 & Weekly Forecast from 22 October to 28 October

Updated: October 27, 2023

Brief information about Incyte Corp.

Ticker: INCY

Sector: Healthcare

Closing price of the last trading day: $54.27

Last trading day: 10/26/2023

Analyst forecast price: $91.88

52-week high/low: $84.86 / $61.91

Shares of Incyte Corp. are traded on the stock exchange under the ticker INCY, marking their space in the competitive "Healthcare" sector. For stakeholders, tracking the dynamic price movement of INCY is crucial for making informed investment decisions. In a market influenced by myriad factors, predicting the trajectory of these shares becomes both a challenge and a necessity. Predictive analytics and data-driven insights play a pivotal role in forecasting the performance of INCY. The investors seeking up-to-date and accurate forecasts for Incyte Corp. shares can turn to resources like Allforecast.com. The website stands out as a reliable tool offering real-time predictions, ensuring that investors are equipped with current and anticipated stock trends. On Allforecast.com, users gain access to a comprehensive analysis and predictions specifically tailored for INCY, spanning varied timeframes - from the next day's anticipations to weekly, monthly, and yearly forecasts. The platform’s real-time updating mechanism ensures that the forecasted data aligns with the ongoing market trends and economic shifts, offering users actionable insights to optimize their investment strategies. The forecasts integrate a mix of qualitative and quantitative analyses, sector-specific trends within "Healthcare", and broader market dynamics to present a holistic view of INCY's expected performance. By leveraging such precise and timely data, investors can strategize their moves, balancing risks and opportunities associated with Incyte Corp.'s stocks. Navigating through the unpredictable terrains of the stock market requires actionable insights and timely data. Allforecast.com serves as a companion for investors eyeing INCY, offering them a blend of accuracy and timeliness in predicting stock movements, aiding in informed and strategic investment choices.

Main Headquarters: Situated at 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US, this location serves as the primary hub for all corporate activities.

Incyte's Current Market Value: As of our last update, it's pegged at $17 206 508 000, indicating its standing in the financial landscape.

Shares Overview: Currently, 221 505 000 shares of Incyte are actively traded and held by the public.

Last year's EBITDA (Earnings Before Interest, Taxes, and Depreciation) for Incyte stood at 681 932 000$. This figure provides insights into the company's operational profitability. With this positive EBITDA, Incyte showcases a favorable financial health.

The PE ratio according to the latest reporting is at around 18.76. P/E shows the investor how many years his investment in this business pays off. That is, investments in Incyte shares will pay off in about 19 years. In principle, this is a good indicator, but it is worth looking at these shares only for a long time.

In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for Incyte shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.

Incyte stock forecast

When considering an investment in Incyte, prospective investors often seek insights on its long-term performance. Our platform consolidates the expert analyses and projections from renowned global analysts to offer a unified consensus forecast for 2023, 2024, 2025, 2026, and 2027.

With these forecasts at your disposal, you can address critical questions like:

What will be the price of one share of Incyte in the subsequent years including 2023, 2024, 2025, 2026, and 2027?

What consensus have the analysts reached regarding the future performance of Incyte stock?

Is Incyte stock a viable option for both short-term and long-term investment?

Is it prudent to sell or hold Incyte shares in 2023?

Is 2023 the opportune moment to buy Incyte stock, or is patience a more viable strategy?

What are the anticipated entry and exit points for investing in Incyte stock, according to expert forecasts?

It’s pivotal to remember that these forecasts are to be utilized as informational resources and not definitive investment advice. The final investment decision rests solely upon the investor, contingent on their risk tolerance, investment goals, and thorough analysis of Incyte.

Insight into Our Forecasting Process

Our forecasting methodology encompasses the aggregation of public and expert data on Incyte, coupled with a sophisticated algorithm that calculates a weighted average forecast while eliminating outliers. This ensures that our audience receives a refined and realistic projection of Incyte stock’s future performance.

Incyte Daily Share Price Forecast for One Month

Our team has meticulously gathered and analyzed forecasts from a diverse pool of analysts to present a consolidated average daily forecast for Incyte shares over the upcoming month. It’s essential to bear in mind that short-term predictions can often be subject to significant volatility, influenced by a myriad of dynamic, real-time market factors.

As you scroll, you’ll discover a detailed graph illustrating the consensus forecast for Incyte stocks over the next 30 days. The gray spectrum of the chart delineates the historical trajectory of the stock’s price, while the turquoise spectrum provides a visual representation of the anticipated price, inclusive of potential fluctuation ranges, offering insights into prospective market trends and stock behaviors.

In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Incyte shares. Our integrated forecast predicts a peak price of $60.04 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of 10.63% from the current standing.

On the flip side, the stock might plummet to a minimum of $52.35 within the same period. A decline of 3.67% signals caution, nudging investors towards a more conservative stance.

Consequently, a fluctuation corridor emerges, with the stock’s resistance at $60.04 and support at $52.35, indicating the oscillating nature of Incyte’s stock over the one-month spectrum. These oscillations, while providing trading opportunities, should be navigated with adept knowledge and strategic foresight.

So, what’s the trajectory of Incyte amidst these projections? The nuances of stock trading and investment are encapsulated in the constant ebb and flow of the market, influenced by intrinsic and extrinsic factors. Hence, a comprehensive, nuanced understanding of market dynamics, coupled with real-time analytics, emerges as the cornerstone for maximizing ROI and mitigating risks.

The evolution of Incyte’s stock is akin to a narrative unfolding, shaped by myriad factors including market trends, economic indicators, and investor sentiment. Each fluctuation is a chapter of this narrative, offering insights, challenges, and opportunities to the discerning investor.

Evaluating the resilience of the support level is crucial in gauging the future trajectory of Incyte shares. The anticipation is that the price will hover near the support level for 3 days. The support level at $52.35 appears to be resilient. However, the volatility in the market and other influencing factors make the downward breach a possibility investors should be wary of.

It’s imperative to remember the innate unpredictability of the stock market. The actual future value of Incyte shares is subject to variables beyond predictive analytics. Nonetheless, investors can expect the stock to oscillate within the defined optimistic and pessimistic target price brackets, offering both challenges and opportunities for strategic trading and investment.

Forecast table for 30 days
Date	Target	Pes.	Opt.	Vol., %
Oct 29	55.01	53.74	56.27	4.70
Oct 30	55.80	55.17	57.06	3.43
Oct 31	54.36	53.42	55.44	3.79
Nov 01	53.76	52.71	54.21	2.85
Nov 02	54.68	53.96	55.25	2.40
Nov 03	55.44	54.17	56.63	4.54
Nov 04	56.25	55.32	57.60	4.12
Nov 05	56.77	55.67	57.39	3.09
Nov 06	57.20	56.70	58.02	2.33
Nov 07	57.85	57.21	58.48	2.21
Nov 08	56.55	55.57	57.57	3.60
Nov 09	55.77	54.98	56.61	2.95
Nov 10	55.10	53.89	55.78	3.50
Nov 11	55.91	54.72	57.18	4.51
Nov 12	56.45	55.33	57.17	3.34
Nov 13	57.75	57.32	58.41	1.90
Nov 14	57.92	57.26	58.48	2.12
Nov 15	57.89	56.99	58.44	2.56
Nov 16	56.92	55.70	57.75	3.68
Nov 17	56.97	55.63	58.03	4.30
Nov 18	57.53	56.22	58.45	3.96
Nov 19	57.43	56.58	58.34	3.11
Nov 20	58.43	57.39	59.32	3.36
Nov 21	58.22	57.64	58.60	1.67
Nov 22	57.87	57.50	58.91	2.45
Nov 23	59.40	58.75	60.04	2.18
Nov 24	57.72	57.17	58.74	2.76
Nov 25	57.08	55.85	57.66	3.25
Nov 26	57.35	56.49	58.61	3.75
Nov 27	55.89	54.78	57.22	4.44

Incyte Stock Forecast 29 Oct.

Presumably, on 10/29/2023, the price of shares will be in the range of $53.74 - $56.27. A $2.53 range width can provide 4.70% volatility. The weighted average price of this range is at $55.01, which is $1.54 higher than the previous day's weighted average price.

Incyte Stock Forecast 30 Oct.

Presumably, on 10/30/2023, the price of shares will be in the range of $55.17 - $57.06. A $1.89 range width can provide 3.43% volatility. The weighted average price of this range is at $55.80, which is $0.79 higher than the previous day's weighted average price.

Incyte Stock Forecast 31 Oct.

Presumably, on 10/31/2023, the price of shares will be in the range of $53.42 - $55.44. A $2.02 range width can provide 3.79% volatility. The weighted average price of this range is at $54.36, which is $1.44 lower than the previous day's weighted average price.

Incyte Stock Forecast 01 Nov.

Presumably, on 11/01/2023, the price of shares will be in the range of $52.71 - $54.21. A $1.50 range width can provide 2.85% volatility. The weighted average price of this range is at $53.76, which is $0.60 lower than the previous day's weighted average price.

Incyte Stock Forecast 02 Nov.

Presumably, on 11/02/2023, the price of shares will be in the range of $53.96 - $55.25. A $1.30 range width can provide 2.40% volatility. The weighted average price of this range is at $54.68, which is $0.92 higher than the previous day's weighted average price.

Incyte Stock Forecast 03 Nov.

Presumably, on 11/03/2023, the price of shares will be in the range of $54.17 - $56.63. A $2.46 range width can provide 4.54% volatility. The weighted average price of this range is at $55.44, which is $0.75 higher than the previous day's weighted average price.

Incyte Stock Forecast 04 Nov.

Presumably, on 11/04/2023, the price of shares will be in the range of $55.32 - $57.60. A $2.28 range width can provide 4.12% volatility. The weighted average price of this range is at $56.25, which is $0.81 higher than the previous day's weighted average price.

Incyte Stock Forecast 05 Nov.

Presumably, on 11/05/2023, the price of shares will be in the range of $55.67 - $57.39. A $1.72 range width can provide 3.09% volatility. The weighted average price of this range is at $56.77, which is $0.52 higher than the previous day's weighted average price.

Incyte Stock Forecast 07 Nov.

Presumably, on 11/07/2023, the price of shares will be in the range of $57.21 - $58.48. A $1.27 range width can provide 2.21% volatility. The weighted average price of this range is at $57.85, which is $0.65 higher than the previous day's weighted average price.

Incyte Stock Forecast 08 Nov.

Presumably, on 11/08/2023, the price of shares will be in the range of $55.57 - $57.57. A $2.00 range width can provide 3.60% volatility. The weighted average price of this range is at $56.55, which is $1.30 lower than the previous day's weighted average price.

Incyte Stock Forecast 09 Nov.

Presumably, on 11/09/2023, the price of shares will be in the range of $54.98 - $56.61. A $1.62 range width can provide 2.95% volatility. The weighted average price of this range is at $55.77, which is $0.78 lower than the previous day's weighted average price.

Incyte Stock Forecast 10 Nov.

Presumably, on 11/10/2023, the price of shares will be in the range of $53.89 - $55.78. A $1.88 range width can provide 3.50% volatility. The weighted average price of this range is at $55.10, which is $0.67 lower than the previous day's weighted average price.

Incyte Stock Forecast 11 Nov.

Presumably, on 11/11/2023, the price of shares will be in the range of $54.72 - $57.18. A $2.47 range width can provide 4.51% volatility. The weighted average price of this range is at $55.91, which is $0.81 higher than the previous day's weighted average price.

Incyte Stock Forecast 12 Nov.

Presumably, on 11/12/2023, the price of shares will be in the range of $55.33 - $57.17. A $1.85 range width can provide 3.34% volatility. The weighted average price of this range is at $56.45, which is $0.54 higher than the previous day's weighted average price.

Incyte Stock Forecast 13 Nov.

Presumably, on 11/13/2023, the price of shares will be in the range of $57.32 - $58.41. A $1.09 range width can provide 1.90% volatility. The weighted average price of this range is at $57.75, which is $1.30 higher than the previous day's weighted average price.

Incyte Stock Forecast 14 Nov.

Presumably, on 11/14/2023, the price of shares will be in the range of $57.26 - $58.48. A $1.22 range width can provide 2.12% volatility. The weighted average price of this range is at $57.92, which is $0.17 higher than the previous day's weighted average price.

Incyte Stock Forecast 15 Nov.

Presumably, on 11/15/2023, the price of shares will be in the range of $56.99 - $58.44. A $1.46 range width can provide 2.56% volatility. The weighted average price of this range is at $57.89, which is $0.03 lower than the previous day's weighted average price.

Incyte Stock Forecast 16 Nov.

Presumably, on 11/16/2023, the price of shares will be in the range of $55.70 - $57.75. A $2.05 range width can provide 3.68% volatility. The weighted average price of this range is at $56.92, which is $0.97 lower than the previous day's weighted average price.

Incyte Stock Forecast 17 Nov.

Presumably, on 11/17/2023, the price of shares will be in the range of $55.63 - $58.03. A $2.39 range width can provide 4.30% volatility. The weighted average price of this range is at $56.97, which is $0.05 higher than the previous day's weighted average price.

Table of forecasts for 2023.
Month	Target	Pes.	Opt.	Vol., %
Nov.	51.97	49.59	53.42	7.18
Dec.	54.50	51.66	56.81	9.07

Diving into a more comprehensive insight, the monthly consensus forecast is an instrumental resource for investors eyeing Incyte's performance metrics. These projections are meticulously curated, leveraging insights from renowned global analysts and offering a panoramic view of the anticipated stock behaviour for the current year and beyond.

In the mid-term analysis, forecasting accuracy enhances, attributed to the diminished influence of transient market fluctuations. For this year, the zenith of Incyte share’s value is anticipated to touch $56.81, offering a robust metric for investment strategies, sans the extremes of varied agency forecasts.

On the contrary, the nadir projections settle at $49.59, delineating the lower threshold and offering a holistic perspective on the risk and return landscape.

Explore Detailed 2023 Forecast

Progressing further, we have extrapolated these analytical insights to generate consensus forecasts for subsequent years. The synthesized data, presented in intuitive tabular formats, offers investors, analysts, and enthusiasts a streamlined view into the future of Incyte stocks.

Anticipated Trends: Incyte (INCY) Monthly Stock Trajectory for 2024

Table of forecasts for 2024.
Month	Target	Pes.	Opt.	Vol., %
Jan	52.59	48.90	54.91	10.95
Feb	54.15	52.88	55.76	5.16
Mar	54.73	50.89	57.49	11.48
Apr	55.57	53.42	59.47	10.18
May	58.37	54.69	60.84	10.10
Jun	55.75	54.34	57.60	5.66
Jul	57.60	54.49	58.90	7.48
Aug	58.12	54.41	59.38	8.37
Sep	59.53	56.59	63.82	11.33
Oct	57.87	56.15	60.22	6.75
Nov	55.84	54.28	58.76	7.61
Dec	59.46	58.17	61.81	5.89

Detailed forecast for 2024

Incyte (INCY) Monthly Stock Prediction for 2025

Table of forecasts for 2025.
Month	Target	Pes.	Opt.	Vol., %
Jan	63.90	59.82	68.04	12.09
Feb	67.35	64.50	69.90	7.72
Mar	64.74	60.43	66.20	8.71
Apr	64.45	60.22	66.43	9.34
May	69.33	64.96	74.13	12.37
Jun	67.77	65.20	69.29	5.90
Jul	70.33	66.91	73.30	8.72
Aug	71.47	68.83	76.48	10.01
Sep	72.24	67.10	74.64	10.10
Oct	71.13	67.68	73.69	8.17
Nov	77.54	72.72	79.70	8.76
Dec	74.67	70.91	79.11	10.36

Detailed forecast for 2025

Incyte (INCY) Monthly Stock Prediction for 2026

Table of forecasts for 2026.
Month	Target	Pes.	Opt.	Vol., %
Jan	79.04	77.26	83.95	7.97
Feb	77.05	75.18	78.72	4.49
Mar	78.92	76.79	80.84	5.01
Apr	71.96	68.27	73.91	7.62
May	68.53	64.71	72.11	10.26
Jun	73.22	69.86	76.25	8.38
Jul	75.33	72.55	78.38	7.44
Aug	72.28	69.02	74.16	6.93
Sep	73.45	68.36	76.29	10.40
Oct	74.77	72.41	79.81	9.27
Nov	75.84	72.98	80.14	8.94
Dec	80.90	77.40	83.15	6.92

Detailed forecast for 2026

Incyte (INCY) Monthly Stock Prediction for 2027

Table of forecasts for 2027.
Month	Target	Pes.	Opt.	Vol., %
Jan	88.18	86.27	90.24	4.40
Feb	80.32	75.26	82.71	9.00
Mar	76.71	73.88	78.09	5.39
Apr	75.19	71.26	79.72	10.61
May	78.30	74.56	80.13	6.95
Jun	76.26	73.30	80.58	9.03
Jul	78.59	74.42	81.21	8.36
Aug	82.13	78.80	88.04	10.49
Sep	84.64	80.14	87.69	8.60
Oct	85.93	81.06	90.57	10.50
Nov	87.02	82.08	89.68	8.47
Dec	85.22	81.00	87.59	7.53

Detailed forecast for 2027

Denial of responsibility:

All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal allforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

Forecast: (INCY) for today October 27 & Weekly Forecast from 22 October to 28 October

Brief information about Incyte Corp.